Switzerland· 62861001
Argatra 100mg/ml, Konzentrat zur Herstellung einer Infusionslösung
A argatroban product containing argatrobanum monohydricum, registered in Switzerland by Medius AG and dispensed under Swissmedic category B. The same ATC class is registered in 11 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Argatroban is registered in 11 of 19 countries.
Countries holding a registration under ATC B01AE03 (argatroban), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 5 of them publish a price we can compare per daily dose
Argatroban · ATC B01AE03
11 / 19 countries
- Canada
- Denmark
- Finlandprice
- Franceprice
- Germany
- Japan
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- argatrobanum monohydricum
- Manufacturer
- Medius AG
- Country
- Switzerland (CH)
- ATC code
- B01AE03
- ATC class
- Argatroban
- Defined daily dose
- 0.2 g, P
- Swissmedic category
- B
- Reimbursed
- No
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
158 interactions on record for argatroban.
Graded by severity as the source publishes them — 72 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Argatroban · interactions on record
158 records
- 72 severe
- 81 moderate
- 5 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- HeparinB01AB01severe
- DalteparinB01AB04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Argatroban in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandNovastanParanova Oy
- NorwayExembol MultidoseEthypharm
- SwedenNovastan 100 mg/ml Koncentrat till infusionsvätska, lösningEthypharm
- United StatesArgatrobanPlano Pharmaceuticals Inc.
- GermanyArgatraEthypharm
- FranceARGANOVA 1 mg/mL, solution pour perfusionETHYPHARM
- United KingdomArgatroban 50mg/50ml solution for infusion vialsAccord-UK Ltd
- NetherlandsArganova Multidose 100 mg/ml concentraat voor oplossing voor infusieEthypharm
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Austria · Argatra, Argatra Multidose
- Germany · Argatra, Argatra Multidose
- Denmark · Novastan
- Spain · Arganova
- Finland · Novastan
- France · Arganova, Argatroban Accord
- United Kingdom (Northern Ireland) · Argatroban Accord Healthcare, Exembol
- Italy · Novastan
- Netherlands · Arganova Multidose
- Norway · Novastan
- Sweden · Novastan, Novastan Multidos
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5f871b86-5c02-4852-8948-59feba63282d GET /v1/drugs/5f871b86-5c02-4852-8948-59feba63282d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about argatroban.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.